Novo Nordisk (NVO.US) submits application in China for the listing of Rybelsus® tablets for long-term weight management
智通财经2026/08/27 04:16Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
According to Zhihui Finance APP, today, the official website of the China National Medical Products Administration's drug review center shows that the marketing application of Novo Nordisk (NVO.US) for Rybelsus® tablets (semaglutide tablets) for long-term weight management has been officially accepted.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
SK hynix (SKHY.US) CEO: Memory shortage is expected to last until the end of 2030.
智通财经•2026/08/27 16:26
Crypto prices
More
Bitcoin
BTC
$80,734.75
+3.14%
Ethereum
ETH
$2,528.3
+3.08%
Tether USDt
USDT
$0.9999
+0.01%
BNB
BNB
$712.15
+2.17%
XRP
XRP
$1.47
+6.05%
USDC
USDC
$0.9999
-0.01%
Solana
SOL
$109.4
+13.30%
TRON
TRX
$0.3381
+1.11%
Hyperliquid
HYPE
$85.78
+6.30%
Dogecoin
DOGE
$0.08983
+6.03%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now